Q linea (QLINEA.ST) Stock Price

Q linea Price

OMX·CLOSED
16.85
​
Market closed

Over the last 9 years Q linea grew revenue by 72.7% annually, reaching 11.10 M SEK. For Q linea, the net margin of -1,644.3% is up versus -2,497.9% a few years ago. The consensus 12-month price target for Q linea is 11.73 SEK, about 30.4% below where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Q linea stock price

Access this data via the Eulerpool API

Q linea business model & stock analysis

Q-linea AB operates as a holding company. The company is headquartered in Uppsala, Uppsala and currently employs 122 full-time employees. The company went IPO on 2018-12-07. The firm develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The firm's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). The company measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. The company is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Frequently asked questions about Q linea

Analysts currently set an average price target of 11.73 SEK for the Q linea stock (median: 11.73 SEK), implying -30.4 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Q linea stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Q linea to generate revenue of 76.80 M SEK and earnings per share of -2.82 SEK.

Converted at the current exchange rate, the Q linea share trades at 1.50 EUR (16.85 SEK).

The Q linea share (QLINEA.ST) is listed on 4 stock exchanges, including: Frankfurt (3F8.F), München (3F8.MU), Stockholm (QLINEA.ST).

The expected revenue of Q linea is 76.80 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Q linea is -35.46 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Q linea is currently -5.97. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Q linea stock.

The price-to-sales ratio (P/S) of Q linea is currently 2.76. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Q linea stock.

The Eulerpool Quality Score for Q linea is 2/10.

The ISIN of Q linea is SE0025420714. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Q linea is A2PASN. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Q linea is QLINEA.ST. The ticker symbol is used to trade Q linea shares on the stock exchange.

Fair ValueTerminal
15.84 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
90,967.21 SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website qlinea.com
Country
Sweden
Currency
SEK
Initial public offering
Dec 7, 2018
ISIN
SE0025420714
Cusip
W7S922112
Market capitalization
108.46 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-5.97
P/Ee 2027
-14.68
P/Ee 2028
10.03
P/Se
2.76
EV/EBIT
2.27
P/B Ratio
0.32
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-53.07 %
Last updated Oct 12, 2026, 12:08 PM

Q linea Peer Group

Q linea Ticker

FRANKFURT · 3F8.FMUNICH · 3F8.MUSTOCKHOLM · QLINEA.STSTOCKHOLM · QLINEA.ST

All fundamentals and in-depth analysis of Q linea

Our stock analysis for Q linea stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Q linea. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.